As of 2026-01-07, the Relative Valuation of Solid Biosciences Inc (SLDB) is (23.11) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.49 USD, the upside of Solid Biosciences Inc based on Relative Valuation is -521.0%.
The range of the Relative Valuation is (16.52) - (31.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.2x - 14.7x | 10.0x |
| Forward P/E multiples | 7.7x - 15.5x | 11.6x |
| Fair Price | (16.52) - (31.45) | (23.11) |
| Upside | -400.9% - -672.8% | -521.0% |
| Date | P/E |
| 2026-01-02 | -2.54 |
| 2025-12-31 | -2.63 |
| 2025-12-30 | -2.66 |
| 2025-12-29 | -2.65 |
| 2025-12-26 | -2.72 |
| 2025-12-24 | -2.75 |
| 2025-12-23 | -2.75 |
| 2025-12-22 | -2.79 |
| 2025-12-19 | -2.77 |
| 2025-12-18 | -2.46 |
| 2025-12-17 | -2.51 |
| 2025-12-16 | -2.71 |
| 2025-12-15 | -2.66 |
| 2025-12-12 | -2.74 |
| 2025-12-11 | -2.74 |
| 2025-12-10 | -2.74 |
| 2025-12-09 | -2.68 |
| 2025-12-08 | -2.66 |
| 2025-12-05 | -2.69 |
| 2025-12-04 | -2.76 |
| 2025-12-03 | -2.42 |
| 2025-12-02 | -2.38 |
| 2025-12-01 | -2.43 |
| 2025-11-28 | -2.53 |
| 2025-11-26 | -2.50 |
| 2025-11-25 | -2.40 |
| 2025-11-24 | -2.29 |
| 2025-11-21 | -2.19 |
| 2025-11-20 | -2.08 |
| 2025-11-19 | -2.09 |
| 2025-11-18 | -2.08 |
| 2025-11-17 | -2.02 |
| 2025-11-14 | -1.98 |
| 2025-11-13 | -2.00 |
| 2025-11-12 | -2.21 |
| 2025-11-11 | -2.11 |
| 2025-11-10 | -1.93 |
| 2025-11-07 | -1.89 |
| 2025-11-06 | -1.96 |
| 2025-11-05 | -1.83 |
| 2025-11-04 | -2.05 |
| 2025-11-03 | -2.42 |
| 2025-10-31 | -2.51 |
| 2025-10-30 | -2.48 |
| 2025-10-29 | -2.56 |
| 2025-10-28 | -2.76 |
| 2025-10-27 | -2.75 |
| 2025-10-24 | -2.62 |
| 2025-10-23 | -2.57 |
| 2025-10-22 | -2.63 |